Should Cosentyx Patients Time Vaccines Apart?
Cosentyx (secukinumab), an IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis, suppresses parts of the immune system. This raises questions about live vaccines, which replicate in the body and could cause infection in immunocompromised patients. Non-live vaccines generally pose less risk but may have reduced effectiveness during treatment.[1]
Live Vaccines: Avoid or Delay Entirely
Patients on Cosentyx should not receive live vaccines. The drug's label states live attenuated vaccines are contraindicated due to potential disseminated infection risks. Discontinue Cosentyx at least 4-6 weeks before live vaccination, if possible, and restart only after consulting a doctor once immune response is confirmed.[2]
Examples include:
- MMR (measles, mumps, rubella)
- Varicella (chickenpox/shingles)
- Oral polio or rotavirus vaccines
Non-Live Vaccines: Timing Recommendations
For inactivated or mRNA vaccines (e.g., COVID-19, flu, Tdap, pneumococcal), no strict contraindication exists. However, Cosentyx may blunt antibody responses, so experts recommend timing when possible:
- Vaccinate before starting Cosentyx, ideally 4 weeks prior.
- If already on treatment, administer non-live vaccines but monitor efficacy; revaccination post-treatment may be needed.
- Separate from dosing? No fixed interval required, but some guidelines suggest vaccinating mid-cycle (e.g., 2 weeks after a dose) to minimize peak suppression, though evidence is limited.[3][4]
| Vaccine Type | Recommendation During Cosentyx | Ideal Timing |
|--------------|--------------------------------|-------------|
| Live (e.g., shingles Zostavax) | Avoid | Stop drug 4+ weeks before; restart after |
| Non-live (e.g., Shingrix, flu shot) | OK, but check response | Before starting or anytime; consider pre-dose |
| COVID-19 mRNA | Recommended; boosters too | No specific separation needed |
What Happens If Vaccinated While on Cosentyx?
Live vaccines risk serious illness; cases of disseminated varicella have occurred with IL-17 inhibitors. Non-live vaccines may fail to build full immunity—studies show 20-50% lower seroprotection rates for flu and pneumococcal shots.[5] Test titers post-vaccination if high-risk (e.g., elderly patients).
Doctor Guidance and Real-World Practice
Rheumatologists often prioritize vaccines before biologic initiation. Per American College of Rheumatology, complete routine vaccines 2-4 weeks pre-treatment. No routine titer checks for all, but for high-stakes ones like hepatitis B, confirm response.[6] Always discuss with your prescriber—personal factors like disease severity or upcoming travel matter.
Related Patient Concerns